Research map: GLP-1 receptor agonists in type 1 diabetes: expanding the therapeutic landscape beyond insulin

Back to the article

Papers in this map

  1. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial · Donna H. Ryan · 2024 · 346 citations · Cited by this paper
  2. Estimating the Potential Burden of Clinically Significant Hantavirus Cases in Argentina · 2026 · Related
  3. GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits · Michael Albrecht Nauck · 2026 · 96 citations · Cited by this paper
  4. Closing the Implementation Gap: New Models of Care to End Chronic Liver Disease · 2026 · Related
  5. Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study · Khary Edwards · 2022 · 92 citations · Cited by this paper
  6. Ending the Chronic Liver Disease Public Health Threat: Systemic Challenges Through the Patient Lens · 2026 · Related
  7. Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance · Maria Apostolopoulou · 2025 · 80 citations · Cited by this paper
  8. Preparing Europe for Recurrent Autochthonous Dengue Transmission: Public Health Implications and Preparedness Priorities · 2026 · Related
  9. GLP-1 Receptor Agonists · Clifford james Rosen · 2026 · 67 citations · Cited by this paper
  10. From Target Engagement to Treatment Governance: The Evolving Role of Amyloid PET in Anti-Amyloid Therapy · 2026 · Related
  11. The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications · Ryan J. Jalleh · 2026 · 28 citations · Cited by this paper
  12. Nordic AI-Health: a unique opportunity for discovery and clinical impact · 2026 · Related
  13. GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects · Pedro Cardoso · 2026 · 14 citations · Cited by this paper
  14. Safety of the Dengue Vaccine TAK-003 and Factors Associated with Adverse Events in Travellers from Non-Endemic Areas: A Real-World Prospective Multicentre Pharmacovigilance Cohort Study in Spain · 2026 · Related
  15. Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis · Kagan Karakus · 2025 · 9 citations · Cited by this paper
  16. Assessing Europe's policy readiness to confront the MASLD/MASH public health threat · 2026 · Related
  17. MiniMed TM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics · Aikaterini Kountouri · 2026 · 1 citation · Cited by this paper
  18. Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension · 2026 · Related

Source: OpenAlex (CC0)